You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Supporting your choice of surgical therapies for your patients with coronary artery disease (CAD).
Since 1997, more than 2 million hearts kept beating during cardiac surgery because of off-pump coronary artery bypass (OPCAB). OPCAB is a coronary artery revascularisation that is performed on a beating heart. Many cardiac surgeons have chosen OPCAB over conventional arrested heart surgery for its many clinical benefits for eligible patients.
OPCAB has been clinically shown to be less invasive than conventional arrested-heart surgery. This technique, which reduces many of the negative effects associated with going on-pump, can be accomplished with the Medtronic Octopus™ technologies, which have enabled many cardiac surgeons to perform more OPCAB procedures.
The OPCAB procedure is effective for many cardiac patients, but not all. Clinical data suggests OPCAB may be an effective alternative for high-risk patients and women.3
Prior to the introduction of cardiopulmonary (CPB), it was common for cardiac surgeons to perform CABG procedures on a beating heart. However, the emergence of CPB and methods of myocardial protection revolutionised CABG procedures by providing a bloodless, motionless heart. While CPB is still the gold standard for many patients, studies suggest performing beating heart surgery to treat coronary artery disease may provide superior outcomes in certain patient populations3
More than 20 years ago, when we introduced the Octopus™ tissue stabilisers for OPCAB, it changed the way cardiac surgeons could perform beating heart surgeries. For the first time, epicardial tissue could be stabilised using vacuum-assisted technology, making direct visualisation possible and completing anastomoses easier. Today, tissue stabilisers are seen as standard for beating heart therapies.
We continue to offer the innovative technologies that help you perform OPCAB procedures. These include the Medtronic Octopus™ Evolutions AS tissue stabiliser and Starfish™ Evo heart positioner, and OctoBase™ sternal retractor. These devices are shown here as positioned in the chest during an OPCAB procedure.
Placement of Devices for OPCAB
The Medtronic Octopus™ Evolution AS tissue stabiliser, Starfish™ Evo heart positioner, and OctoBase™ sternal retractor placed for OPCAB.
The Medtronic Octopus AS Tissue Stabiliser
Tissue stabilisers are a standard part of OPCAB procedures.
Off-Pump Coronary Artery Bypass (OPCAB) procedures are becoming more mainstream today. As the patient population changes, so do the demands on you, the cardiac surgeon. That’s why Medtronic is committed to supporting OPCAB. Together — with your skilled knowledge and our enabling technologies — we can deliver the right therapies for each individual patient with coronary artery disease (CAD).
Learn new beating heart skills and gain hands-on experience with technologies that may be new to you. We offer a full range of training programs. Contact us to learn more.
Medtronic Data on File
Puskas J, Cheng D, Knight J, et al. Off-pump versus conventional coronary artery bypass grafting: a meta-analysis and consensus statement from the 2004 ISMICS Consensus Conference. Innovations. 2005; 1: 3-27.
Puskas J, Thourani V, Kilgo P, et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. Ann Thorac Surg. 2009;88:1142-7.
Mack MJ, Brown P, Houser F, et al. On-pump versus off-pump coronary artery bypass surgery in a matched sample outcome of women. A comparison of outcomes. Circulation. 2004; 110, (suppl II):II-1-II-6.
Reston JT, Tregear SJ, Turkelson cm. Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg. 2003; 76:1510-15.
Cheng DC, Bainbridge D, Martin JE, Novick RJ; The Evidence-based Perioperative Outcomes Research Group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology. 2005; 102:188-203.
Singh A, Mehta Y. Intraoperative aortic dissection. Annals of Cardiac Anaesthesia. 2015;18(4):537-542. doi:10.4103/0971-9784.166463.
Not all patients are candidates for beating heart procedures. Some patients would require cardiopulmonary support during surgery.
See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.
For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu. For applicable products, consult instructions for use on manuals.medtronic.com. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.